12. Archaeosome Vaccine Adjuvants for Cross-Priming CD8+ T-Cell Immunity

  1. Manmohan Singh M. Pharm., Ph.D.
  1. Lakshmi Krishnan and
  2. G. Dennis Sprott

Published Online: 2 NOV 2006

DOI: 10.1002/9780470134931.ch12

Vaccine Adjuvants and Delivery Systems

Vaccine Adjuvants and Delivery Systems

How to Cite

Krishnan, L. and Sprott, G. D. (2007) Archaeosome Vaccine Adjuvants for Cross-Priming CD8+ T-Cell Immunity, in Vaccine Adjuvants and Delivery Systems (ed M. Singh), John Wiley & Sons, Inc., Hoboken, NJ, USA. doi: 10.1002/9780470134931.ch12

Editor Information

  1. Novartis Vaccines, Emeryville, California, USA

Author Information

  1. Institute for Biological Sciences, National Research Council of Canada, Ottawa, Ontario, Canada

Publication History

  1. Published Online: 2 NOV 2006
  2. Published Print: 15 JUN 2007

ISBN Information

Print ISBN: 9780471739074

Online ISBN: 9780470134931

SEARCH

Keywords:

  • archaeosome vaccine adjuvants;
  • archaeal lipid structures;
  • archaeosomes and strong CD8+ T-cell immunity

Summary

This chapter contains sections titled:

  • Introduction

  • Archaeal Lipid Structures

  • Archaeosome Characteristics

  • Adjuvant Effects of Archaeosomes

  • Vaccine Applications

  • Biocompatibility

  • Summary and Future Challenges

  • References